HD17: PET guided omission of radiotherapy in Hodgkin lymphoma

1 Views
administrator
administrator
07/09/23

Peter Borchmann, MD , University Hospital Cologne, Cologne, Germany, discusses HD17 (NCT01356680), a Phase III trial of PET-guided omission of radiotherapy in early-stage unfavorable Hodgkin lymphoma patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next